Research study Program year 2019 Source: CMS Open Payments

Medication Overuse Headache Study (MOH)

Research payments

$198,600

55 payments

Through program year 2019, $198,600 in research payments was reported against Medication Overuse Headache Study (MOH), across 55 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$198,600	55

Breakdown

Who paid Research payments · program year 2019

Amgen Inc. $198,600 55 payments

Who received the money Research payments · program year 2019

University of South Florida Organisation paid for research $20,762 2 payments
Nashville Neuroscience Group Organisation paid for research $17,685 3 payments
Michigan Headache And Neurological Organisation paid for research $16,829 2 payments
Mercy Research Organisation paid for research $11,762 3 payments
Dent Neurosciences Research Center Organisation paid for research $11,521 3 payments
Dent Neurologic Institute Organisation paid for research $11,383 1 payment
Preferred Primary Care Physicians Organisation paid for research $11,350 1 payment
Clinical Research Institute INC Organisation paid for research $11,186 2 payments
Medical Faculty Associates INC Organisation paid for research $10,784 1 payment
Delricht LLC Delricht Research Organisation paid for research $8,650 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.